朗姿股份(002612.SZ):擬以2.5億元投設醫美股權投資基金博恆一號
格隆匯11月19日丨朗姿股份(002612.SZ)公佈,公司為抓住行業發展的良好機遇,加快醫美業務的戰略佈局,進一步推進構建泛時尚產業互聯生態圈的戰略部署,2021年11月19日,公司與參股公司北京朗姿韓亞資產管理有限公司(“朗姿韓亞資管”或“交易對方”)籤訂附生效條件的《蕪湖博恆一號股權投資合夥企業(有限合夥)合夥協議》。
公司擬以自有資金2.5億元人民幣,作為有限合夥人出資設立醫美股權投資基金—蕪湖博恆一號股權投資合夥企業(有限合夥)(暫定名,最終以工商登記機關核定為準,“合夥企業”),該基金採用合夥企業方式運營,普通合夥人為朗姿韓亞資管,主要通過股權投資的形式投資於醫療美容領域及其相關產業的未上市公司股權,基金規模為5.01億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.